These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8991640)

  • 1. Specific antibody response to oligomannosidic epitopes in Crohn's disease.
    Sendid B; Colombel JF; Jacquinot PM; Faille C; Fruit J; Cortot A; Lucidarme D; Camus D; Poulain D
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):219-26. PubMed ID: 8991640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological differentiation of inflammatory bowel diseases.
    Conrad K; Schmechta H; Klafki A; Lobeck G; Uhlig HH; Gerdi S; Henker J
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):129-35. PubMed ID: 11981336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.
    McKenzie H; Main J; Pennington CR; Parratt D
    Gut; 1990 May; 31(5):536-8. PubMed ID: 2190866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG; Kim YS; Kim JS; Jung HC; Song IS
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
    Giaffer MH; Clark A; Holdsworth CD
    Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.
    Darroch CJ; Barnes RM; Dawson J
    J Clin Pathol; 1999 Jan; 52(1):47-53. PubMed ID: 10343612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
    Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
    Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
    Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
    Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
    Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
    Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.